Different patterns in the prognostic value of age for bladder cancer-specific survival depending on tumor stages.
To compare the pathological features and long-term survival of bladder cancer (BCa) in young patients with elderly counterparts. Using the U.S. National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) population-based data, we identified 93115 patients with non-metastatic bladder cancer diagnosed between 1988 and 2003. Patients were categorized into young (50 years and under) and elderly groups (over 50 years of age). The overall and five-year bladder cancer specific survival (BCSS) data were obtained using Kaplan-Meier plots. Multivariable Cox regression models were built for the analysis of long-term survival outcomes and risk factors. There were significant differences between the two groups in primary site, pathologic grading, histologic type, AJCC stage (p<0.001). The overall and 5-year cancer specific survival rates were 88.1% and 90.8% in young group, 64.8% and 81.3% in elderly group, which had significant difference in both univariate and multivariate analysis (p<0.001). Further analysis showed this significant difference existed across all the AJCC stage patients. The study findings show different patterns in the prognostic value of age for determining BCSS, depending on the tumor stages. Compared with elderly patients, young patients with bladder cancer surgery appear to have unique characteristics and a higher overall and cancer specific survival rate.
Department of Urology, The Bayi Hospital of PLA Nanjing, People's Republic of China.
Huan
H
Feng
Department of Urology, The Bayi Hospital of PLA Nanjing, People's Republic of China.
Wei
W
Zhang
Department of Urology, The Bayi Hospital of PLA Nanjing, People's Republic of China.
Jiajun
J
Li
Department of Urology, The Bayi Hospital of PLA Nanjing, People's Republic of China.
Xiaozhe
X
Lu
Prognostic value; age; bladder cancer; survival